[PLX] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 100.76%
YoY- 104.15%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 10,967 12,247 2,006 6,358 1,769 4,616 2,686 26.39%
PBT -4,150 -7,743 -11,294 450 -10,736 -5,071 -6,119 -6.26%
Tax 38 3 75 3,045 213 43 202 -24.28%
NP -4,150 -7,743 -11,294 450 -10,853 -5,071 -6,119 -6.26%
Tax Rate - - - -676.67% - - - -
Total Cost 15,117 19,990 13,300 5,908 12,622 9,687 8,805 9.41%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -37.84 -63.22 -563.01 7.08 -613.51 -109.86 -227.81 -25.83%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -0.13 -0.52 -0.77 0.04 -0.11 -0.05 -0.07 10.85%
EPS Diluted -0.13 -0.52 -0.77 -0.60 -0.11 -0.05 -0.07 10.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.